TABLE 3.

Demographic and Clinical Characteristics of the 2533 Study Participants^a,b

Characteristic	Value
Age (y), mean ± SD	62.2±7.7
Female sex (No. [%])	1453 (57.4)
White race (No. [%])	2465 (97.3)
Body mass index, mean ± SD	30.3±5.9
Electrocardiogram (No. [%])	2304 (91.0)
Echocardiogram (No. [%])	1092 (43.1)
Lipid profiles
Median LDL-C (mg/dL), mean ± SD	166.8±39.3
Maximum LDL-C (mg/dL) , mean ± SD	170.3±41.0
Triglycerides (mg/dL), mean ± SD	263.9±265.7
Statin use (No. [%])	125 (4.9)
Maximum LDL-C ≥155 mg/dL (No. [%])	1752 (69.4)
Maximum LDL-C ≥190 mg/dL (No. [%])	640 (25.2)
Maximum triglyceride level > 150 mg/dL (No. [%])	1856 (73.3)
Maximum triglyceride level >500 mg/dL (No. [%])	198 (7.8)
Primary indication for testing
Hyperlipidemia (No. [%])	1351 (53.3)
Colon polyp (No. [%])	599 (23.6)
Colon polyp + hyperlipidemia (No. [%])	583 (23.0)

^aLDL-C = low-density lipoprotein cholesterol (in participants who were taking statins, the LDL-C level was imputed).

^bSI conversion factors: To convert LDL-C values to mmol/L, multiply by 0.0259; to convert triglyceride values to mmol/L, multiply by 0.0113.